Literature DB >> 23071221

Poor evidence to standardize adjuvant treatment for patients with biliary tract cancer.

Giovanni M Bariani, Maria Ignez Braghiroli, Rachel P Riechelmann.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23071221     DOI： 10.1200/JCO.2012.44.1634

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).

Authors:  Masanori Toyoda; Tetsuo Ajiki; Yutaka Fujiwara; Hiroaki Nagano; Shogo Kobayashi; Daisuke Sakai; Etsuro Hatano; Masashi Kanai; Shoji Nakamori; Atsushi Miyamoto; Akihito Tsuji; Satoshi Kaihara; Hisashi Ikoma; Shigekazu Takemura; Hideyoshi Toyokawa; Hiroaki Terajima; Satoshi Morita; Tatsuya Ioka
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-11       Impact factor: 3.333

2.  Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

Authors:  Xiaobo Bo; Jie Wang; Qiang Fu; Yueqi Wang; Houbao Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2017-07-27

3.  Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis.

Authors:  Ning Ma; Hui Cheng; Baodong Qin; Renqian Zhong; Bin Wang
Journal:  BMC Cancer       Date:  2015-09-03       Impact factor: 4.430

4.  Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.

Authors:  Alexander Stein; Dirk Arnold; John Bridgewater; David Goldstein; Lars Henrik Jensen; Heinz-Josef Klümpen; Ansgar W Lohse; Björn Nashan; John Primrose; Silke Schrum; Jenny Shannon; Eik Vettorazzi; Henning Wege
Journal:  BMC Cancer       Date:  2015-07-31       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.